Literature DB >> 22284746

Diurnal expression of the thrombopoietin gene is regulated by CLOCK.

C J Tracey1, X Pan, J H Catterson, A J Harmar, M M Hussain, P S Hartley.   

Abstract

BACKGROUND: Most physiologic processes exhibit diurnal fluctuations controlled by the circadian regulation of sleep-wake behavior and feeding cycles. In addition, many cell types express endogenous circadian rhythms that affect cell-specific processes. Independent reports support the hypothesis that thrombopoietin (TPO) is under circadian control.
OBJECTIVES: The current study tested the hypothesis that CLOCK, a circadian transcription factor, may regulate Thpo, the gene encoding TPO.
METHODS: Circadian gene expression patterns were analyzed in mice and in human cell lines, Small interfering RNA was used to knock down CLOCK expression in cell lines, and gene expression was also examined in Clock(Δ19/Δ19) mutant mice.
RESULTS: It was found that there was a diurnal rhythm in the expression of Thpoin vivo in mice, and that this was associated with concomitant rhythms of protein abundance. Thpo was rhythmically expressed in human cell lines, consistent with the gene being directly or indirectly regulated by the circadian clock. Silencing of CLOCK in the Huh7 human hepatoma cell line led to a significant reduction in the rhythmicity of Thpo expression. The expression of Mpl in murine marrow also displayed diurnal rhythmicity in vivo. In Clock(Δ19/Δ19) mutant mice, Thpo and Mpl expression was disrupted and there was an increase in the number of mature megakaryocytes, but no change in the ploidy distribution within the megakaryocyte population.
CONCLUSIONS: These findings establish that Clock regulates Thpo and Mpl expression in vivo, and demonstrate an important link between the body's circadian timing mechanisms and megakaryopoiesis.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284746     DOI: 10.1111/j.1538-7836.2012.04643.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity.

Authors:  Abhay Singh; Anupam Verma; Soniya Nityanand; Rajendra Chaudhary; Priti Elhence
Journal:  Asian J Transfus Sci       Date:  2015 Jan-Jun

2.  Intense light as anticoagulant therapy in humans.

Authors:  Yoshimasa Oyama; Sydney Shuff; Pavel Davizon-Castillo; Nathan Clendenen; Tobias Eckle
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

3.  Biological clocks: The coming of age.

Authors:  Chandrashekhar V Apte
Journal:  Int J Appl Basic Med Res       Date:  2012-01

Review 4.  Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury.

Authors:  Yoshimasa Oyama; Lori A Walker; Tobias Eckle
Journal:  Chronobiol Int       Date:  2021-05-25       Impact factor: 3.749

5.  Role of circadian gene Clock during differentiation of mouse pluripotent stem cells.

Authors:  Chao Lu; Yang Yang; Ran Zhao; Bingxuan Hua; Chen Xu; Zuoqin Yan; Ning Sun; Ruizhe Qian
Journal:  Protein Cell       Date:  2016-09-23       Impact factor: 14.870

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.